Lamotrigine and exogenous estrogen among females with epilepsy: A retrospective analysis of administrative claims data
CONCLUSION: Dose increase of lamotrigine following addition of exogenous estrogen is rare among U.S. FWE, with potential disparities based on age and income level. More guidance may be needed for providers on this topic.PMID:37931389 | DOI:10.1016/j.yebeh.2023.109514
Source: Epilepsy and Behaviour - Category: Neurology Authors: Laura Kirkpatrick Samuel W Terman Elizabeth Harrison Page B Pennell Source Type: research
More News: Databases & Libraries | Epilepsy | Hormone Replacement Therapy | Hormones | Lamictal | Neurology